Literature DB >> 20812779

Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.

Bénédicte Cauwe1, Ghislain Opdenakker.   

Abstract

Matrix metalloproteinases (MMPs), originally discovered to function in the breakdown of extracellular matrix proteins, have gained the status of regulatory proteases in signaling events by liganding and processing hormones, cytokines, chemokines, adhesion molecules and other membrane receptors. However, MMPs also cleave intracellular substrates and have been demonstrated within cells in nuclear, mitochondrial, various vesicular and cytoplasmic compartments, including the cytoskeletal intracellular matrix. Unbiased high-throughput degradomics approaches have demonstrated that many intracellular proteins are cleaved by MMPs, including apoptotic regulators, signal transducers, molecular chaperones, cytoskeletal proteins, systemic autoantigens, enzymes in carbohydrate metabolism and protein biosynthesis, transcriptional and translational regulators, and proteins in charge of protein clearance such as lysosomal and ubiquitination enzymes. Besides proteolysis inside cells, intracellular proteins may also be modulated by MMPs in the extracellular milieu. Indeed, many intracellular proteins exit cells by non-classical secretion mechanisms or by various conditions of cell death by apoptosis, necrosis and NETosis, and become accessible to extracellular proteases. Intracellular substrate proteolysis by MMPs is involved in innate immune defense and apoptosis, and affects oncogenesis and pathology of cardiac, neurological, protein conformational and autoimmune diseases, including ischemia-reperfusion injury, cardiomyopathy, Parkinson's disease, cataract, multiple sclerosis and systemic lupus erythematosus. Since the same MMP may affect physiology and pathology in different and even opposite ways, depending on its extracellular or subcellular localization, an additional layer of complexity is added to therapeutic MMP inhibition. Hence, further elucidation of intracellular MMP localizations and intracellular substrate proteolysis is a new challenge in MMP research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812779     DOI: 10.3109/10409238.2010.501783

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  89 in total

1.  Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization.

Authors:  John M Wallis; Zachary D Borg; Amanda B Daly; Bin Deng; Bryan A Ballif; Gilman B Allen; Diane M Jaworski; Daniel J Weiss
Journal:  Tissue Eng Part C Methods       Date:  2012-01-26       Impact factor: 3.056

2.  A rapid lung de-cellularization protocol supports embryonic stem cell differentiation in vitro and following implantation.

Authors:  Todd Jensen; Blair Roszell; Fan Zang; Eric Girard; Adam Matson; Roger Thrall; Diane M Jaworski; Cayla Hatton; Daniel J Weiss; Christine Finck
Journal:  Tissue Eng Part C Methods       Date:  2012-04-17       Impact factor: 3.056

3.  What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?

Authors:  Ferdinando Mannello
Journal:  BMC Med       Date:  2011-08-11       Impact factor: 8.775

Review 4.  Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Authors:  Nikolaos G Frangogiannis; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

5.  Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9.

Authors:  Karina Zitta; Patrick Meybohm; Berthold Bein; Christin Heinrich; Jochen Renner; Jochen Cremer; Markus Steinfath; Jens Scholz; Martin Albrecht
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 6.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

7.  Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia.

Authors:  Yi Yang; Eduardo Candelario-Jalil; Jeffrey F Thompson; Eloy Cuadrado; Eduardo Y Estrada; Anna Rosell; Joan Montaner; Gary A Rosenberg
Journal:  J Neurochem       Date:  2009-10-15       Impact factor: 5.372

Review 8.  Myocardial matrix metalloproteinase-2: inside out and upside down.

Authors:  Ashley DeCoux; Merry L Lindsey; Francisco Villarreal; Ricardo A Garcia; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2014-09-28       Impact factor: 5.000

Review 9.  The extracellular matrix in myocardial injury, repair, and remodeling.

Authors:  Nikolaos G Frangogiannis
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

10.  Syndecan-1 Shedding Inhibition to Protect Against Ischemic Acute Kidney Injury Through HGF Target Signaling Pathway.

Authors:  Zhihui Lu; Nana Song; Bo Shen; XiaLian Xu; Yi Fang; Yiqin Shi; Yichun Ning; Jiachang Hu; Yan Dai; Xiaoqiang Ding; Jianzhou Zou; Jie Teng
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.